Does ENZALUTAMIDE Cause Neoplasm? 51 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Neoplasm have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
51
Reports of Neoplasm with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
13
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm From ENZALUTAMIDE?
Of the 51 reports, 13 (25.5%) resulted in death, 11 (21.6%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Neoplasm Listed in the Official Label?
Yes, Neoplasm is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which ENZALUTAMIDE Alternatives Have Lower Neoplasm Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE